His primary areas of study are Immunology, Eosinophil, Eosinophilic esophagitis, Eotaxin and Eosinophilia. All of his Immunology and Interleukin 13, Interleukin 5, Inflammation, Cytokine and Pathogenesis investigations are sub-components of the entire Immunology study. His studies in Eosinophil integrate themes in fields like Molecular biology, Cell biology and Pathology.
His biological study spans a wide range of topics, including Esophagus, Esophageal disease and Gastroenterology. His Eotaxin study incorporates themes from CCR3, Chemotaxis, Lung and Interferon gamma. In his study, Intensive care medicine and Proton-pump inhibitor is inextricably linked to MEDLINE, which falls within the broad field of Eosinophilia.
His main research concerns Immunology, Eosinophilic esophagitis, Eosinophil, Internal medicine and Eosinophilia. Eotaxin, Interleukin 5, Interleukin 13, Inflammation and Chemokine are among the areas of Immunology where the researcher is concentrating his efforts. The various areas that he examines in his Eotaxin study include CCR3 and Chemotaxis.
His studies deal with areas such as Esophagus and Eosinophilic as well as Eosinophilic esophagitis. His Eosinophil research includes themes of Molecular biology, Immune system, Cytokine and Allergy. His Internal medicine research includes elements of Gastroenterology, Placebo, Endocrinology and Dysphagia.
Marc E. Rothenberg mainly investigates Eosinophilic esophagitis, Internal medicine, Gastroenterology, Immunology and Eosinophil. The Eosinophilic esophagitis study combines topics in areas such as Interleukin 13 and Eosinophilic. His Internal medicine research incorporates themes from Placebo and Dysphagia.
The Eosinophilic gastritis research Marc E. Rothenberg does as part of his general Gastroenterology study is frequently linked to other disciplines of science, such as High-power field, therefore creating a link between diverse domains of science. His research brings together the fields of Single-nucleotide polymorphism and Immunology. He works mostly in the field of Eosinophil, limiting it down to topics relating to Eosinophilia and, in certain cases, Proton-pump inhibitor, as a part of the same area of interest.
Marc E. Rothenberg focuses on Eosinophilic esophagitis, Internal medicine, Eosinophil, Immunology and Cancer research. His Eosinophilic esophagitis research is within the category of Disease. His Internal medicine study combines topics in areas such as Gastroenterology, Cross-sectional study, Endocrinology and Dysphagia.
His Eosinophil research is multidisciplinary, incorporating elements of Eosinophilia, Apoptosis, Receptor, Interleukin 4 and Peripheral blood. His Immunology research integrates issues from Single-nucleotide polymorphism and Linkage disequilibrium. His work carried out in the field of Cancer research brings together such families of science as Proinflammatory cytokine, CCL24, Signal transduction and Viperin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
Chris A. Liacouras;Glenn T. Furuta;Ikuo Hirano;Dan Atkins.
The Journal of Allergy and Clinical Immunology (2011)
Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.
Glenn T. Furuta;Chris A. Liacouras;Margaret H. Collins;Sandeep K. Gupta.
Eosinophilic gastrointestinal disorders (EGID)
Marc E Rothenberg.
The Journal of Allergy and Clinical Immunology (2004)
Eosinophils: Biological Properties and Role in Health and Disease
Simon P. Hogan;Helene F. Rosenberg;Redwan Moqbel;Simon Phipps.
Clinical & Experimental Allergy (2008)
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis
Carine Blanchard;Ning Wang;Keith F. Stringer;Anil Mishra.
Journal of Clinical Investigation (2006)
Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.
Eduardo A. Garcia-Zepeda;Marc E. Rothenberg;Robert T. Ownbey;Jocelyn Celestin.
Nature Medicine (1996)
An etiological role for aeroallergens and eosinophils in experimental esophagitis
Anil Mishra;Simon P. Hogan;Eric B. Brandt;Marc E. Rothenberg.
Journal of Clinical Investigation (2001)
MicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression
Thomas X. Lu;Ariel Munitz;Marc E. Rothenberg.
Journal of Immunology (2009)
A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic Esophagitis
Michael R. Konikoff;Richard J. Noel;Carine Blanchard;Cassie Kirby.
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
Marc E. Rothenberg;James A. MacLean;Eric Pearlman;Andrew D. Luster.
Journal of Experimental Medicine (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: